151
|
Guba W, Meyder A, Rarey M, Hert J. Torsion Library Reloaded: A New Version of Expert-Derived SMARTS Rules for Assessing Conformations of Small Molecules. J Chem Inf Model 2015; 56:1-5. [DOI: 10.1021/acs.jcim.5b00522] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Wolfgang Guba
- Molecular
Design and Chemical Biology, Roche Pharma Research and Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Agnes Meyder
- Center
for Bioinformatics, University of Hamburg, Bundesstrasse 43, D-20146 Hamburg, Germany
| | - Matthias Rarey
- Center
for Bioinformatics, University of Hamburg, Bundesstrasse 43, D-20146 Hamburg, Germany
| | - Jérôme Hert
- Molecular
Design and Chemical Biology, Roche Pharma Research and Early Development
(pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| |
Collapse
|
152
|
Kowalkowska A, Jończyk A. [1,2] Stevens sigmatropic rearrangement of pyrrolidinium ylides—simple synthesis of 3-aryl-2-cyano-1-methylpiperidines. Tetrahedron 2015. [DOI: 10.1016/j.tet.2015.10.076] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
153
|
Lauber BS, Hardegger LA, Asraful AK, Lund BA, Dumele O, Harder M, Kuhn B, Engh RA, Diederich F. Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB Mimic. Chemistry 2015; 22:211-21. [DOI: 10.1002/chem.201503552] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2015] [Indexed: 12/25/2022]
|
154
|
Stark DG, Morrill LC, Cordes DB, Slawin AMZ, O'Riordan TJC, Smith AD. Enantioselective Synthesis of 3,5,6-Substituted Dihydropyranones and Dihydropyridinones using Isothiourea-Mediated Catalysis. Chem Asian J 2015; 11:395-400. [PMID: 26471245 PMCID: PMC4755233 DOI: 10.1002/asia.201500907] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Indexed: 02/02/2023]
Abstract
The scope of dihydropyranone and dihydropyridinone products accessible by isothiourea-catalyzed processes has been expanded and explored through the use of 2-N-tosyliminoacrylates and 2-aroylacrylates in a Michael addition-lactonization/lactamization cascade reaction. Notably, to ensure reproducibility it is essential to use homoanhydrides as ammonium enolate precursors with 2-aroyl acrylates, while carboxylic acids can be used with 2-N-tosyliminoacrylates, delivering a range of 3,5,6-substituted dihydropyranones and dihydropyridinones with high enantioselectivity (typically >90 % ee). The derivatization of the heterocyclic core of a 3,5,6-substituted dihydropyranone through hydrogenation is also reported.
Collapse
Affiliation(s)
- Daniel G Stark
- School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife, KY16 9ST, UK
| | - Louis C Morrill
- School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife, KY16 9ST, UK
| | - David B Cordes
- School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife, KY16 9ST, UK
| | - Alexandra M Z Slawin
- School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife, KY16 9ST, UK
| | - Timothy J C O'Riordan
- Syngenta, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK
| | - Andrew D Smith
- School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife, KY16 9ST, UK.
| |
Collapse
|
155
|
Tucker JW, Chenard L, Young JM. Selective Access to Heterocyclic Sulfonamides and Sulfonyl Fluorides via a Parallel Medicinal Chemistry Enabled Method. ACS COMBINATORIAL SCIENCE 2015; 17:653-7. [PMID: 26434694 DOI: 10.1021/acscombsci.5b00120] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A sulfur-functionalized aminoacrolein derivative is used for the efficient and selective synthesis of heterocyclic sulfonyl chlorides, sulfonyl fluorides, and sulfonamides. The development of a 3-step parallel medicinal chemistry (PMC) protocol for the synthesis of pyrazole-4-sulfonamides effectively demonstrates the utility of this reagent. This reactivity was expanded to provide rapid access to other heterocyclic sulfonyl fluorides, including pyrimidines and pyridines, whose corresponding sulfonyl chlorides lack suitable chemical stability.
Collapse
Affiliation(s)
- Joseph W. Tucker
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Lois Chenard
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Joseph M. Young
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
156
|
Thelemann J, Illarionov B, Barylyuk K, Geist J, Kirchmair J, Schneider P, Anthore L, Root K, Trapp N, Bacher A, Witschel M, Zenobi R, Fischer M, Schneider G, Diederich F. Aryl Bis-Sulfonamide Inhibitors of IspF from Arabidopsis thaliana and Plasmodium falciparum. ChemMedChem 2015; 10:2090-8. [PMID: 26435072 DOI: 10.1002/cmdc.201500382] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Indexed: 01/23/2023]
Abstract
2-Methylerythritol 2,4-cyclodiphosphate synthase (IspF) is an essential enzyme for the biosynthesis of isoprenoid precursors in plants and many human pathogens. The protein is an attractive target for the development of anti-infectives and herbicides. Using a photometric assay, a screen of 40 000 compounds on IspF from Arabidopsis thaliana afforded symmetrical aryl bis-sulfonamides that inhibit IspF from A. thaliana (AtIspF) and Plasmodium falciparum (PfIspF) with IC50 values in the micromolar range. The ortho-bis-sulfonamide structural motif is essential for inhibitory activity. The best derivatives obtained by parallel synthesis showed IC50 values of 1.4 μm against PfIspF and 240 nm against AtIspF. Substantial herbicidal activity was observed at a dose of 2 kg ha(-1) . Molecular modeling studies served as the basis for an in silico search targeted at the discovery of novel, non-symmetrical sulfonamide IspF inhibitors. The designed compounds were found to exhibit inhibitory activities in the double-digit micromolar IC50 range.
Collapse
Affiliation(s)
- Jonas Thelemann
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Boris Illarionov
- Institut für Lebensmittelchemie, Universität Hamburg, Grindelallee 117, 20146, Hamburg, Germany
| | - Konstantin Barylyuk
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Julie Geist
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Johannes Kirchmair
- Zentrum für Bioinformatik, Universität Hamburg, Bundesstr. 43, 20146, Hamburg, Germany
| | - Petra Schneider
- Institut für Pharmazeutische Wissenschaften, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Lucile Anthore
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Katharina Root
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Nils Trapp
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland
| | - Adelbert Bacher
- Lehrstuhl für Biochemie, Technische Universität München, Lichtenbergerstr. 4, 85748, Garching, Germany
| | | | - Renato Zenobi
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland.
| | - Markus Fischer
- Institut für Lebensmittelchemie, Universität Hamburg, Grindelallee 117, 20146, Hamburg, Germany.
| | - Gisbert Schneider
- Institut für Pharmazeutische Wissenschaften, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland.
| | - François Diederich
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland.
| |
Collapse
|
157
|
Kothiwale S, Mendenhall JL, Meiler J. BCL::Conf: small molecule conformational sampling using a knowledge based rotamer library. J Cheminform 2015; 7:47. [PMID: 26473018 PMCID: PMC4607025 DOI: 10.1186/s13321-015-0095-1] [Citation(s) in RCA: 68] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2015] [Accepted: 09/03/2015] [Indexed: 12/14/2022] Open
Abstract
The interaction of a small molecule with a protein target depends on its ability to adopt a three-dimensional structure that is complementary. Therefore, complete and rapid prediction of the conformational space a small molecule can sample is critical for both structure- and ligand-based drug discovery algorithms such as small molecule docking or three-dimensional quantitative structure–activity relationships. Here we have derived a database of small molecule fragments frequently sampled in experimental structures within the Cambridge Structure Database and the Protein Data Bank. Likely conformations of these fragments are stored as ‘rotamers’ in analogy to amino acid side chain rotamer libraries used for rapid sampling of protein conformational space. Explicit fragments take into account correlations between multiple torsion bonds and effect of substituents on torsional profiles. A conformational ensemble for small molecules can then be generated by recombining fragment rotamers with a Monte Carlo search strategy. BCL::Conf was benchmarked against other conformer generator methods including Confgen, Moe, Omega and RDKit in its ability to recover experimentally determined protein bound conformations of small molecules, diversity of conformational ensembles, and sampling rate. BCL::Conf recovers at least one conformation with a root mean square deviation of 2 Å or better to the experimental structure for 99 % of the small molecules in the Vernalis benchmark dataset. The ‘rotamer’ approach will allow integration of BCL::Conf into respective computational biology programs such as Rosetta.Conformation sampling is carried out using explicit fragment conformations derived from crystallographic structure databases. Molecules from the database are decomposed into fragments and most likely conformations/rotamers are used to sample correspondng sub-structure of a molecule of interest. ![]()
Collapse
Affiliation(s)
- Sandeepkumar Kothiwale
- Department of Chemistry, Center for Structural Biology, Vanderbilt University, Nashville, TN 37232 USA
| | - Jeffrey L Mendenhall
- Department of Chemistry, Center for Structural Biology, Vanderbilt University, Nashville, TN 37232 USA
| | - Jens Meiler
- Department of Chemistry, Center for Structural Biology, Vanderbilt University, Nashville, TN 37232 USA ; Department of Pharmacology and Biomedical Informatics, Vanderbilt University, Nashville, TN 37212 USA
| |
Collapse
|
158
|
Xu Y, Conner ML, Brown MK. Cyclobutane and cyclobutene synthesis: catalytic enantioselective [2+2] cycloadditions. Angew Chem Int Ed Engl 2015; 54:11918-28. [PMID: 26333192 DOI: 10.1002/anie.201502815] [Citation(s) in RCA: 216] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2015] [Indexed: 12/21/2022]
Abstract
Cyclobutanes and cyclobutenes are important structural motifs found in numerous biologically significant molecules, and they are useful intermediates for chemical synthesis. Consequently, [2+2] cycloadditions to access cyclobutanes and cyclobutenes have been established to be particularly useful transformations. Within the last 10 years, an increase in the frequency of publications for catalytic enantioselective [2+2] cycloadditions has occurred. These reactions provide access to a wide array of enantiomerically enriched chemical diversity that was not previously attainable. Described in this review are the advances made in catalytic enantioselective [2+2] cycloadditions to access cyclobutanes and cyclobutenes.
Collapse
Affiliation(s)
- Yao Xu
- Department of Chemistry, Indiana University, 800 E. Kirkwood Ave., Bloomington, IN 47405 (USA)
| | - Michael L Conner
- Department of Chemistry, Indiana University, 800 E. Kirkwood Ave., Bloomington, IN 47405 (USA)
| | - M Kevin Brown
- Department of Chemistry, Indiana University, 800 E. Kirkwood Ave., Bloomington, IN 47405 (USA).
| |
Collapse
|
159
|
Xu Y, Conner ML, Brown MK. Synthese von Cyclobutanen und Cyclobutenen: katalytische enantioselektive [2+2]-Cycloadditionen. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201502815] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
160
|
Young JM, Lee AG, Chandrasekaran RY, Tucker JW. The Synthesis of Alkyl and (Hetero)aryl Sulfonamides From Sulfamoyl Inner Salts. J Org Chem 2015; 80:8417-23. [DOI: 10.1021/acs.joc.5b01287] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Joseph M. Young
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Aisha G. Lee
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Ramalakshmi Y. Chandrasekaran
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Joseph W. Tucker
- Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
161
|
Abstract
The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties associated with this unusual element and how to deploy it with greater sophistication. The judicious introduction of fluorine into a molecule can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties. In addition, (18)F has been established as a useful positron emitting isotope for use with in vivo imaging technology that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compounds. The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compounds. In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug molecules and applications in positron emission tomography.
Collapse
Affiliation(s)
- Eric P Gillis
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Kyle J Eastman
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Matthew D Hill
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - David J Donnelly
- Discovery Chemistry Platforms, PET Radiochemical Synthesis, Bristol-Myers Squibb Research and Development , P.O. Box 4000, Princeton, New Jersey 08543, United States
| | - Nicholas A Meanwell
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492, United States
| |
Collapse
|
162
|
Smith SR, Fallan C, Taylor JE, McLennan R, Daniels DSB, Morrill LC, Slawin AMZ, Smith AD. Asymmetric Isothiourea-Catalysed Formal [3+2] Cycloadditions of Ammonium Enolates with Oxaziridines. Chemistry 2015; 21:10530-6. [PMID: 26073559 PMCID: PMC4531819 DOI: 10.1002/chem.201501271] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2015] [Indexed: 11/07/2022]
Abstract
A highly enantioselective Lewis base-catalysed formal [3+2] cycloaddition of ammonium enolates and oxaziridines to give stereodefined oxazolidin-4-ones in high yield is described. Employing an enantioenriched oxaziridine in this process leads to a matched/mis-matched effect with the isothiourea catalyst and allowed the synthesis of either syn- or anti-stereodefined oxazolidin-4-ones in high d.r., yield and ee. Additionally, the oxazolidin-4-one products have been derivatised to afford functionalised enantioenriched building blocks.
Collapse
Affiliation(s)
- Siobhan R Smith
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - Charlene Fallan
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - James E Taylor
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - Ross McLennan
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - David S B Daniels
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - Louis C Morrill
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - Alexandra M Z Slawin
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK)
| | - Andrew D Smith
- EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST (UK).
| |
Collapse
|
163
|
Fong CW. Binding energies of tyrosine kinase inhibitors: Error assessment of computational methods for imatinib and nilotinib binding. Comput Biol Chem 2015; 58:40-54. [PMID: 26025598 DOI: 10.1016/j.compbiolchem.2015.05.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2014] [Revised: 05/09/2015] [Accepted: 05/13/2015] [Indexed: 11/30/2022]
Abstract
The binding energies of imatinib and nilotinib to tyrosine kinase have been determined by quantum mechanical (QM) computations, and compared with literature binding energy studies using molecular mechanics (MM). The potential errors in the computational methods include these critical factors. Errors in X-ray structures such as structural distortions and steric clashes give unrealistically high van der Waals energies, and erroneous binding energies.MM optimization gives a very different configuration to the QM optimization for nilotinib, whereas the imatinib ion gives similar configurations. Solvation energies are a major component of the overall binding energy. The QM based solvent model (PCM/SMD) gives different values from those used in the implicit PBSA solvent MM models. A major error in inhibitor—kinase binding lies in the non-polar solvation terms. Solvent transfer free energies and the required empirical solvent accessible surface area factors for nilotinib and imatinib ion to give the transfer free energies have been reverse calculated. These values differ from those used in the MM PBSA studies.An intertwined desolvation—conformational binding selectivity process is a balance of thermodynamic desolvation and intramolecular conformational kinetic control.The configurational entropies (TΔS) are minor error sources.
Collapse
|
164
|
Harder M, Carnero Corrales MA, Trapp N, Kuhn B, Diederich F. Rebek Imide Platforms as Model Systems for the Investigation of Weak Intermolecular Interactions. Chemistry 2015; 21:8455-63. [DOI: 10.1002/chem.201500462] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Indexed: 11/09/2022]
|
165
|
|
166
|
Fukata Y, Asano K, Matsubara S. Facile Net Cycloaddition Approach to Optically Active 1,5-Benzothiazepines. J Am Chem Soc 2015; 137:5320-3. [DOI: 10.1021/jacs.5b02537] [Citation(s) in RCA: 102] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Yukihiro Fukata
- Department of Material Chemistry,
Graduate School of Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo, Kyoto 615-8510, Japan
| | - Keisuke Asano
- Department of Material Chemistry,
Graduate School of Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo, Kyoto 615-8510, Japan
| | - Seijiro Matsubara
- Department of Material Chemistry,
Graduate School of Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo, Kyoto 615-8510, Japan
| |
Collapse
|
167
|
Beno BR, Yeung KS, Bartberger MD, Pennington LD, Meanwell NA. A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. J Med Chem 2015; 58:4383-438. [DOI: 10.1021/jm501853m] [Citation(s) in RCA: 468] [Impact Index Per Article: 52.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Brett R. Beno
- Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway Wallingford Connecticut 06492, United States
| | - Kap-Sun Yeung
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway Wallingford Connecticut 06492, United States
| | - Michael D. Bartberger
- Department of Therapeutic Discovery, Amgen Inc., One Amgen Center Drive Thousand Oaks California 91320, United States
| | - Lewis D. Pennington
- Department of Therapeutic Discovery, Amgen Inc., One Amgen Center Drive Thousand Oaks California 91320, United States
| | - Nicholas A. Meanwell
- Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway Wallingford Connecticut 06492, United States
| |
Collapse
|
168
|
Persch E, Dumele O, Diederich F. Molekulare Erkennung in chemischen und biologischen Systemen. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201408487] [Citation(s) in RCA: 102] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
169
|
Persch E, Dumele O, Diederich F. Molecular recognition in chemical and biological systems. Angew Chem Int Ed Engl 2015; 54:3290-327. [PMID: 25630692 DOI: 10.1002/anie.201408487] [Citation(s) in RCA: 424] [Impact Index Per Article: 47.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2014] [Indexed: 12/13/2022]
Abstract
Structure-based ligand design in medicinal chemistry and crop protection relies on the identification and quantification of weak noncovalent interactions and understanding the role of water. Small-molecule and protein structural database searches are important tools to retrieve existing knowledge. Thermodynamic profiling, combined with X-ray structural and computational studies, is the key to elucidate the energetics of the replacement of water by ligands. Biological receptor sites vary greatly in shape, conformational dynamics, and polarity, and require different ligand-design strategies, as shown for various case studies. Interactions between dipoles have become a central theme of molecular recognition. Orthogonal interactions, halogen bonding, and amide⋅⋅⋅π stacking provide new tools for innovative lead optimization. The combination of synthetic models and biological complexation studies is required to gather reliable information on weak noncovalent interactions and the role of water.
Collapse
Affiliation(s)
- Elke Persch
- Laboratorium für Organische Chemie, Departement Chemie und Angewandte Biowissenschaften, ETH Zürich, Vladimir-Prelog-Weg 3, 8093 Zürich (Switzerland)
| | | | | |
Collapse
|
170
|
Fauber BP, Clagg K, Gibbons P, René O. Experimental and Computational Studies of the Diastereoselective Alkylations of 3-Substituted γ-Sultams. J Org Chem 2015; 80:685-9. [PMID: 25437310 DOI: 10.1021/jo502506j] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We report that chiral 3-substituted γ-sultam α-carbanions undergo diastereoselective alkylation reactions with alkyl halides to predominantly produce trans-3,5-disubstituted γ-sultam products. Quantum mechanical calculations provided a stereoelectronic rationale for the observed diastereoselectivity.
Collapse
Affiliation(s)
- Benjamin P Fauber
- Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Kyle Clagg
- Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Paul Gibbons
- Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Olivier René
- Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| |
Collapse
|
171
|
Yeh PP, Daniels DSB, Fallan C, Gould E, Simal C, Taylor JE, Slawin AMZ, Smith AD. Exploring the scope of the isothiourea-mediated synthesis of dihydropyridinones. Org Biomol Chem 2015; 13:2177-91. [DOI: 10.1039/c4ob02408g] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The exploration and expansion of the scope of the isothiourea-mediated synthesis of dihydropyridinones is presented.
Collapse
Affiliation(s)
- Pei-Pei Yeh
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| | | | - Charlene Fallan
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| | - Eoin Gould
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| | - Carmen Simal
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| | - James E. Taylor
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| | | | - Andrew D. Smith
- EaStCHEM
- School of Chemistry
- University of St Andrews
- North Haugh
- UK
| |
Collapse
|
172
|
García-Deibe AM, Portela-García C, Fondo M, Sanmartín-Matalobos J. Controlling ring-chain tautomerism through steric hindrance. RSC Adv 2015. [DOI: 10.1039/c5ra10132h] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Adequate substituents can favour/hinder, the tautomerisation of Schiff bases into tetrahydroquinazolines, by means of strong/weak H bonds.
Collapse
Affiliation(s)
- Ana M. García-Deibe
- Dpto. Química Inorgánica
- Fac. Química
- Univ. Santiago de Compostela
- Santiago de Compostela
- Spain
| | | | - Matilde Fondo
- Dpto. Química Inorgánica
- Fac. Química
- Univ. Santiago de Compostela
- Santiago de Compostela
- Spain
| | | |
Collapse
|
173
|
Akune Y, Gontani H, Hirosawa R, Koseki A, Matsumoto S. The effects of molecular flexibility and substituents on conformational polymorphism in a series of 2,5-diamino-3,6-dicyanopyrazine dyes with highly flexible groups. CrystEngComm 2015. [DOI: 10.1039/c5ce01004g] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The flexibility of the dibenzylamino groups and the terminal substituents played an important role in the conformational polymorphism of diaminodicyanopyrazine dyes.
Collapse
Affiliation(s)
- Yoko Akune
- Graduate School of Environmental and Information Sciences
- Yokohama National University
- Yokohama 240-8501, Japan
| | - Haruyuki Gontani
- Graduate School of Environmental and Information Sciences
- Yokohama National University
- Yokohama 240-8501, Japan
| | - Risa Hirosawa
- Graduate School of Environmental and Information Sciences
- Yokohama National University
- Yokohama 240-8501, Japan
| | - Atsushi Koseki
- Graduate School of Environmental and Information Sciences
- Yokohama National University
- Yokohama 240-8501, Japan
| | - Shinya Matsumoto
- Graduate School of Environmental and Information Sciences
- Yokohama National University
- Yokohama 240-8501, Japan
| |
Collapse
|
174
|
Adamczyk-Woźniak A, Czerwińska K, Madura ID, Matuszewska A, Sporzyński A, Żubrowska-Zembrzuska A. Piperazine derivatives of boronic acids – potential bifunctional biologically active compounds. NEW J CHEM 2015. [DOI: 10.1039/c5nj00084j] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The combination of a piperazine and boronic groups within one molecule can result in a totally novel biological activity.
Collapse
Affiliation(s)
| | | | - Izabela D. Madura
- Faculty of Chemistry
- Warsaw University of Technology
- 00-664 Warsaw
- Poland
| | | | | | | |
Collapse
|
175
|
Makam P, Kannan T. 2-Aminothiazole derivatives as antimycobacterial agents: Synthesis, characterization, in vitro and in silico studies. Eur J Med Chem 2014; 87:643-56. [DOI: 10.1016/j.ejmech.2014.09.086] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2014] [Revised: 06/21/2014] [Accepted: 09/09/2014] [Indexed: 10/24/2022]
|
176
|
Audran G, Brémond P, Marque SR, Siri D, Santelli M. Energetics of the biosynthesis of cyclopentenones from unsaturated fatty acids. Tetrahedron 2014. [DOI: 10.1016/j.tet.2014.09.056] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
177
|
Juárez-Jiménez J, Barril X, Orozco M, Pouplana R, Luque FJ. Assessing the suitability of the multilevel strategy for the conformational analysis of small ligands. J Phys Chem B 2014; 119:1164-72. [PMID: 25319869 DOI: 10.1021/jp506779y] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Predicting the conformational preferences of flexible compounds is a challenging problem in drug design, where the recognition between ligand and receptor is affected by the ability of the interacting partners to adopt a favorable conformation for the binding. To explore the conformational space of flexible ligands and to obtain the relative free energy of the conformation wells, we have recently reported a multilevel computational strategy that relies on the predominant-state approximation-where the conformational space is partitioned into distinct conformational wells-and combines a low-level method for sampling the conformational minima and high-level ab initio calculations for estimating their relative stability. In this study, we assess the performance of the multilevel strategy for predicting the conformational preferences of a series of structurally related phenylethylamines and streptomycin in aqueous solution. The charged nature of these compounds and the chemical complexity of streptomycin make them a challenging test for the multilevel approach. Furthermore, we explore the suitability of using a molecular mechanics approach as a source of approximate ensembles in the first stage of the multilevel strategy. The results support the reliability of the multilevel approach for obtaining an accurate conformational ensemble of small (bio)organic molecules in aqueous solution.
Collapse
Affiliation(s)
- Jordi Juárez-Jiménez
- Departament de Fisicoquímica and Institut de Biomedicina (IBUB), Facultat de Farmàcia, Universitat de Barcelona , Avda. Prat de la Riba, 171, 08921 Santa Coloma de Gramenet, Spain
| | | | | | | | | |
Collapse
|
178
|
Morrill LC, Stark DG, Taylor JE, Smith SR, Squires JA, D'Hollander ACA, Simal C, Shapland P, O'Riordan TJC, Smith AD. Organocatalytic Michael addition–lactonisation of carboxylic acids using α,β-unsaturated trichloromethyl ketones as α,β-unsaturated ester equivalents. Org Biomol Chem 2014; 12:9016-27. [DOI: 10.1039/c4ob01788a] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
179
|
Wang L, Stanley M, Boggs JW, Crawford TD, Bravo BJ, Giannetti AM, Harris SF, Magnuson SR, Nonomiya J, Schmidt S, Wu P, Ye W, Gould SE, Murray LJ, Ndubaku CO, Chen H. Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. Bioorg Med Chem Lett 2014; 24:4546-4552. [PMID: 25139565 DOI: 10.1016/j.bmcl.2014.07.071] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2014] [Revised: 07/24/2014] [Accepted: 07/28/2014] [Indexed: 01/27/2023]
Abstract
MAP4K4 has been shown to regulate key cellular processes that are tied to disease pathogenesis. In an effort to generate small molecule MAP4K4 inhibitors, a fragment-based screen was carried out and a pyrrolotriazine fragment with excellent ligand efficiency was identified. Further modification of this fragment guided by X-ray crystal structures and molecular modeling led to the discovery of a series of promising compounds with good structural diversity and physicochemical properties. These compounds exhibited single digit nanomolar potency and compounds 35 and 44 achieved good in vivo exposure.
Collapse
Affiliation(s)
- Lan Wang
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Mark Stanley
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Jason W Boggs
- Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Terry D Crawford
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Brandon J Bravo
- Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Anthony M Giannetti
- Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Seth F Harris
- Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Steven R Magnuson
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Jim Nonomiya
- Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Stephen Schmidt
- Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Ping Wu
- Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Weilan Ye
- Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Stephen E Gould
- Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Lesley J Murray
- Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States
| | - Chudi O Ndubaku
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
| | - Huifen Chen
- Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.
| |
Collapse
|
180
|
Taylor R, Cole J, Korb O, McCabe P. Knowledge-Based Libraries for Predicting the Geometric Preferences of Druglike Molecules. J Chem Inf Model 2014; 54:2500-14. [DOI: 10.1021/ci500358p] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Robin Taylor
- Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, United Kingdom
| | - Jason Cole
- Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, United Kingdom
| | - Oliver Korb
- Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, United Kingdom
| | - Patrick McCabe
- Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, United Kingdom
| |
Collapse
|
181
|
Alonso JA, Andrés M, Bravo M, Buil MA, Calbet M, Castro J, Eastwood PR, Esteve C, Ferrer M, Forns P, Gómez E, González J, Lozoya E, Mir M, Moreno I, Petit S, Roberts RS, Sevilla S, Vidal B, Vidal L, Vilaseca P. Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: the role of a hydrogen-bond acceptor in long receptor residence times. Bioorg Med Chem Lett 2014; 24:5127-33. [PMID: 25437506 DOI: 10.1016/j.bmcl.2014.08.028] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Revised: 08/07/2014] [Accepted: 08/08/2014] [Indexed: 12/23/2022]
Abstract
The correct positioning and orientation of an hydrogen bond acceptor (HBA) in the tail portion of the biaryl series of CRTh2 antagonists is a requirement for long receptor residence time. The HBA in combination with a small steric substituent in the core section (R(core) ≠ H) gives access to compounds with dissociation half-lives of ⩾ 24h.
Collapse
Affiliation(s)
- Juan Antonio Alonso
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Miriam Andrés
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Mónica Bravo
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Maria Antonia Buil
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Marta Calbet
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Jordi Castro
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Paul R Eastwood
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Cristina Esteve
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Manel Ferrer
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Pilar Forns
- Almirall-Barcelona Science Park Unit, Barcelona Science Park, Josep Samitier 1-5, 08028 Barcelona, Spain
| | - Elena Gómez
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Jacob González
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Estrella Lozoya
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Marta Mir
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Imma Moreno
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Silvia Petit
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Richard S Roberts
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain.
| | - Sara Sevilla
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Bernat Vidal
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Laura Vidal
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| | - Pere Vilaseca
- Almirall R&D Centre, Laureano Miró, 408-410, 08980 Sant Feliu de Llobregat, Barcelona, Spain
| |
Collapse
|
182
|
Reid RC, Yau MK, Singh R, Lim J, Fairlie DP. Stereoelectronic effects dictate molecular conformation and biological function of heterocyclic amides. J Am Chem Soc 2014; 136:11914-7. [PMID: 25102224 DOI: 10.1021/ja506518t] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Heterocycles adjacent to amides can have important influences on molecular conformation due to stereoelectronic effects exerted by the heteroatom. This was shown for imidazole- and thiazole-amides by comparing low energy conformations (ab initio MP2 and DFT calculations), charge distribution, dipole moments, and known crystal structures which support a general principle. Switching a heteroatom from nitrogen to sulfur altered the amide conformation, producing different three-dimensional electrostatic surfaces. Differences were attributed to different dipole and orbital alignments and spectacularly translated into opposing agonist vs antagonist functions in modulating a G-protein coupled receptor for inflammatory protein complement C3a on human macrophages. Influences of the heteroatom were confirmed by locking the amide conformation using fused bicyclic rings. These findings show that stereoelectronic effects of heterocycles modulate molecular conformation and can impart strikingly different biological properties.
Collapse
Affiliation(s)
- Robert C Reid
- Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland , Brisbane, QLD 4072, Australia
| | | | | | | | | |
Collapse
|
183
|
Belmessieri D, de la Houpliere A, Calder EDD, Taylor JE, Smith AD. Stereodivergent organocatalytic intramolecular Michael addition/lactonization for the asymmetric synthesis of substituted dihydrobenzofurans and tetrahydrofurans. Chemistry 2014; 20:9762-9. [PMID: 24989672 PMCID: PMC4517160 DOI: 10.1002/chem.201402684] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2014] [Indexed: 11/19/2022]
Abstract
A stereodivergent asymmetric Lewis base catalyzed Michael addition/lactonization of enone acids into substituted dihydrobenzofuran and tetrahydrofuran derivatives is reported. Commercially available (S)-(-)-tetramisole hydrochloride gives products with high syn diastereoselectivity in excellent enantioselectivity (up to 99:1 d.r.syn/anti , 99 % eesyn ), whereas using a cinchona alkaloid derived catalyst gives the corresponding anti-diastereoisomers as the major product (up to 10:90 d.r.syn/anti , 99 % eeanti ).
Collapse
Affiliation(s)
- Dorine Belmessieri
- EaStCHEM, School of Chemistry, University of St. AndrewsNorth Haugh, St. Andrews, KY16 9ST (UK) E-mail:
| | - Alix de la Houpliere
- EaStCHEM, School of Chemistry, University of St. AndrewsNorth Haugh, St. Andrews, KY16 9ST (UK) E-mail:
| | - Ewen D D Calder
- EaStCHEM, School of Chemistry, University of St. AndrewsNorth Haugh, St. Andrews, KY16 9ST (UK) E-mail:
| | - James E Taylor
- EaStCHEM, School of Chemistry, University of St. AndrewsNorth Haugh, St. Andrews, KY16 9ST (UK) E-mail:
| | - Andrew D Smith
- EaStCHEM, School of Chemistry, University of St. AndrewsNorth Haugh, St. Andrews, KY16 9ST (UK) E-mail:
| |
Collapse
|
184
|
Schiebel J, Chang A, Shah S, Lu Y, Liu L, Pan P, Hirschbeck MW, Tareilus M, Eltschkner S, Yu W, Cummings JE, Knudson SE, Bommineni GR, Walker SG, Slayden RA, Sotriffer CA, Tonge PJ, Kisker C. Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor. J Biol Chem 2014; 289:15987-6005. [PMID: 24739388 DOI: 10.1074/jbc.m113.532804] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Determining the molecular basis for target selectivity is of particular importance in drug discovery. The ideal antibiotic should be active against a broad spectrum of pathogenic organisms with a minimal effect on human targets. CG400549, a Staphylococcus-specific 2-pyridone compound that inhibits the enoyl-acyl carrier protein reductase (FabI), has recently been shown to possess human efficacy for the treatment of methicillin-resistant Staphylococcus aureus infections, which constitute a serious threat to human health. In this study, we solved the structures of three different FabI homologues in complex with several pyridone inhibitors, including CG400549. Based on these structures, we rationalize the 65-fold reduced affinity of CG400549 toward Escherichia coli versus S. aureus FabI and implement concepts to improve the spectrum of antibacterial activity. The identification of different conformational states along the reaction coordinate of the enzymatic hydride transfer provides an elegant visual depiction of the relationship between catalysis and inhibition, which facilitates rational inhibitor design. Ultimately, we developed the novel 4-pyridone-based FabI inhibitor PT166 that retained favorable pharmacokinetics and efficacy in a mouse model of S. aureus infection with extended activity against Gram-negative and mycobacterial organisms.
Collapse
Affiliation(s)
- Johannes Schiebel
- From the Rudolf Virchow Center for Experimental Biomedicine, Institute for Structural Biology, University of Wuerzburg, D-97080 Wuerzburg, Germany, the Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Am Hubland, D-97074 Wuerzburg, Germany
| | - Andrew Chang
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and School of Dental Medicine, Department of Oral Biology and Pathology, Stony Brook University, Stony Brook, New York 11794-3400, and
| | - Sonam Shah
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Yang Lu
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and School of Dental Medicine, Department of Oral Biology and Pathology, Stony Brook University, Stony Brook, New York 11794-3400, and
| | - Li Liu
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Pan Pan
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Maria W Hirschbeck
- From the Rudolf Virchow Center for Experimental Biomedicine, Institute for Structural Biology, University of Wuerzburg, D-97080 Wuerzburg, Germany
| | - Mona Tareilus
- From the Rudolf Virchow Center for Experimental Biomedicine, Institute for Structural Biology, University of Wuerzburg, D-97080 Wuerzburg, Germany
| | - Sandra Eltschkner
- From the Rudolf Virchow Center for Experimental Biomedicine, Institute for Structural Biology, University of Wuerzburg, D-97080 Wuerzburg, Germany
| | - Weixuan Yu
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Jason E Cummings
- the Rocky Mountain Regional Center of Excellence and Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682
| | - Susan E Knudson
- the Rocky Mountain Regional Center of Excellence and Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682
| | - Gopal R Bommineni
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Stephen G Walker
- School of Dental Medicine, Department of Oral Biology and Pathology, Stony Brook University, Stony Brook, New York 11794-3400, and
| | - Richard A Slayden
- the Rocky Mountain Regional Center of Excellence and Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682
| | - Christoph A Sotriffer
- the Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Am Hubland, D-97074 Wuerzburg, Germany
| | - Peter J Tonge
- the Institute for Chemical Biology and Drug Discovery, Department of Chemistry, and
| | - Caroline Kisker
- From the Rudolf Virchow Center for Experimental Biomedicine, Institute for Structural Biology, University of Wuerzburg, D-97080 Wuerzburg, Germany,
| |
Collapse
|
185
|
Nasveschuk CG, Gagnon A, Garapaty-Rao S, Balasubramanian S, Campbell R, Lee C, Zhao F, Bergeron L, Cummings R, Trojer P, Audia JE, Albrecht BK, Harmange JCP. Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2. ACS Med Chem Lett 2014; 5:378-83. [PMID: 24900844 DOI: 10.1021/ml400494b] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2013] [Accepted: 01/14/2014] [Indexed: 12/26/2022] Open
Abstract
The identification and development of a novel series of small molecule Enhancer of Zeste Homologue 2 (EZH2) inhibitors is described. A concise and modular synthesis enabled the rapid development of structure-activity relationships, which led to the identification of 44 as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.
Collapse
Affiliation(s)
- Christopher G. Nasveschuk
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Alexandre Gagnon
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Shivani Garapaty-Rao
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Srividya Balasubramanian
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Robert Campbell
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Christina Lee
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Feng Zhao
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Louise Bergeron
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Richard Cummings
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Patrick Trojer
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - James E. Audia
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | - Brian K. Albrecht
- Constellation Pharmaceuticals, 215
1st Street, Suite 200, Cambridge, Massachusetts 02142, United States
| | | |
Collapse
|
186
|
West TH, Daniels DSB, Slawin AMZ, Smith AD. An Isothiourea-Catalyzed Asymmetric [2,3]-Rearrangement of Allylic Ammonium Ylides. J Am Chem Soc 2014; 136:4476-9. [DOI: 10.1021/ja500758n] [Citation(s) in RCA: 124] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Thomas H. West
- EaStCHEM,
School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, U.K
| | - David S. B. Daniels
- EaStCHEM,
School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, U.K
| | - Alexandra M. Z. Slawin
- EaStCHEM,
School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, U.K
| | - Andrew D. Smith
- EaStCHEM,
School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, U.K
| |
Collapse
|
187
|
Halland N, Blum H, Buning C, Kohlmann M, Lindenschmidt A. Small Macrocycles As Highly Active Integrin α2β1 Antagonists. ACS Med Chem Lett 2014; 5:193-8. [PMID: 24900800 DOI: 10.1021/ml4004556] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2013] [Accepted: 01/08/2014] [Indexed: 01/17/2023] Open
Abstract
Starting from clinical candidates Firategrast, Valategrast, and AJM-300, a series of novel macrocyclic platelet collagen receptor α2β1 antagonists were developed. The amino acid derived low molecular weight 14-18-membered macrocycles turned out to be highly active toward integrin α2β1 with IC50s in the low nanomolar range. The conformation of the macrocycles was found to be highly important for the activity, and an X-ray crystal structure was obtained to clarify this. Subsequent docking into the metal-ion-dependent adhesion site (MIDAS) of a β1 unit revealed a binding model indicating key binding features. Macrocycle 38 was selected for further in vitro and in vivo profiling.
Collapse
Affiliation(s)
- Nis Halland
- Sanofi R&D, Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany
| | - Horst Blum
- Sanofi R&D, Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany
| | - Christian Buning
- Sanofi R&D, Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany
| | - Markus Kohlmann
- Sanofi R&D, Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany
| | | |
Collapse
|
188
|
Kirschberg TA, Squires NH, Yang H, Corsa AC, Tian Y, Tirunagari N, Sheng XC, Kim CU. Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease. Bioorg Med Chem Lett 2014; 24:969-72. [DOI: 10.1016/j.bmcl.2013.12.060] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Revised: 12/13/2013] [Accepted: 12/16/2013] [Indexed: 11/25/2022]
|
189
|
Meanwell NA. The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. TACTICS IN CONTEMPORARY DRUG DESIGN 2014; 9. [PMCID: PMC7416817 DOI: 10.1007/7355_2013_29] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The application of bioisosteres in drug discovery is a well-established design concept that has demonstrated utility as an approach to solving a range of problems that affect candidate optimization, progression, and durability. In this chapter, the application of isosteric substitution is explored in a fashion that focuses on the development of practical solutions to problems that are encountered in typical optimization campaigns. The role of bioisosteres to affect intrinsic potency and selectivity, influence conformation, solve problems associated with drug developability, including P-glycoprotein recognition, modulating basicity, solubility, and lipophilicity, and to address issues associated with metabolism and toxicity is used as the underlying theme to capture a spectrum of creative applications of structural emulation in the design of drug candidates.
Collapse
|
190
|
Belema M, Nguyen VN, Romine JL, St. Laurent DR, Lopez OD, Goodrich JT, Nower PT, O’Boyle DR, Lemm JA, Fridell RA, Gao M, Fang H, Krause RG, Wang YK, Oliver AJ, Good AC, Knipe JO, Meanwell NA, Snyder LB. Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons. J Med Chem 2014; 57:1995-2012. [DOI: 10.1021/jm4016203] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Makonen Belema
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Van N. Nguyen
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Jeffrey L. Romine
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Denis R. St. Laurent
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Omar D. Lopez
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Jason T. Goodrich
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Peter T. Nower
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Donald R. O’Boyle
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Julie A. Lemm
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Robert A. Fridell
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Min Gao
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Hua Fang
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Rudolph G. Krause
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Ying-Kai Wang
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - A. Jayne Oliver
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Andrew C. Good
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Jay O. Knipe
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Nicholas A. Meanwell
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| | - Lawrence B. Snyder
- Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States
| |
Collapse
|
191
|
Groom CR, Allen FH. Die Cambridge Structural Database: Rückblick und Vorausschau. Angew Chem Int Ed Engl 2014. [DOI: 10.1002/ange.201306438] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
192
|
Groom CR, Allen FH. The Cambridge Structural Database in Retrospect and Prospect. Angew Chem Int Ed Engl 2014; 53:662-71. [PMID: 24382699 DOI: 10.1002/anie.201306438] [Citation(s) in RCA: 881] [Impact Index Per Article: 88.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2013] [Indexed: 11/07/2022]
Affiliation(s)
- Colin R Groom
- Executive Director, Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ (United Kingdom).
| | | |
Collapse
|
193
|
Chen IJ, Foloppe N. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery. Bioorg Med Chem 2013; 21:7898-920. [DOI: 10.1016/j.bmc.2013.10.003] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2013] [Revised: 09/29/2013] [Accepted: 10/04/2013] [Indexed: 02/01/2023]
|
194
|
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc. Bioorg Med Chem Lett 2013; 23:6604-9. [DOI: 10.1016/j.bmcl.2013.10.054] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2013] [Revised: 10/23/2013] [Accepted: 10/25/2013] [Indexed: 12/15/2022]
|
195
|
Hilpert H, Mauser H, Humm R, Anselm L, Kuehne H, Hartmann G, Gruener S, Banner DW, Benz J, Gsell B, Kuglstatter A, Stihle M, Thoma R, Sanchez RA, Iding H, Wirz B, Haap W. Identification of Potent and Selective Cathepsin S Inhibitors Containing Different Central Cyclic Scaffolds. J Med Chem 2013; 56:9789-801. [DOI: 10.1021/jm401528k] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Hans Hilpert
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Harald Mauser
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Roland Humm
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Lilli Anselm
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Holger Kuehne
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Guido Hartmann
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Sabine Gruener
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - David W. Banner
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Joerg Benz
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Bernard Gsell
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Andreas Kuglstatter
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Martine Stihle
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Ralf Thoma
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Rubén Alvarez Sanchez
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Hans Iding
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Beat Wirz
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Wolfgang Haap
- Discovery Chemistry, ‡Cardiovascular and
Metabolic Diseases, §Discovery Technologies, ∥Drug Metabolism
and Pharmacokinetics, ⊥Process Research and Synthesis, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel CH-4070, Switzerland
| |
Collapse
|
196
|
Kawate T, Iwase N, Shimizu M, Stanley SA, Wellington S, Kazyanskaya E, Hung DT. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32. Bioorg Med Chem Lett 2013; 23:6052-9. [PMID: 24103299 DOI: 10.1016/j.bmcl.2013.09.035] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2013] [Revised: 09/07/2013] [Accepted: 09/11/2013] [Indexed: 11/16/2022]
Abstract
In an effort to develop new and potent agents for therapy against tuberculosis, a high-throughput screen was performed against Mycobacterium tuberculosis strain H37Rv. Two 6-aryl-5,7-dimethyl-4-phenylcoumarin compounds 1a and 1b were found with modest activity. A series of coumarin derivatives were synthesized to improve potency and to investigate the structure-activity relationship of the series. Among them, compounds 1o and 2d showed improved activity with IC90 of 2 μM and 0.5 μM, respectively. Further optimization provided compound 3b with better physiochemical properties with IC90 0.4 μM which had activity in a mouse model of infection. The role of the conformation of the 4- and 6-aryl substituents is also described.
Collapse
Affiliation(s)
- Tomohiko Kawate
- The Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA; Department of Molecular Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Center for Computational and Integrative, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Department of Microbiology and Immunobiology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
| | | | | | | | | | | | | |
Collapse
|
197
|
Schärfer C, Schulz-Gasch T, Hert J, Heinzerling L, Schulz B, Inhester T, Stahl M, Rarey M. CONFECT: Conformations from an Expert Collection of Torsion Patterns. ChemMedChem 2013; 8:1690-700. [DOI: 10.1002/cmdc.201300242] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Revised: 07/04/2013] [Indexed: 11/09/2022]
|
198
|
Okaniwa M, Hirose M, Arita T, Yabuki M, Nakamura A, Takagi T, Kawamoto T, Uchiyama N, Sumita A, Tsutsumi S, Tottori T, Inui Y, Sang BC, Yano J, Aertgeerts K, Yoshida S, Ishikawa T. Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives. J Med Chem 2013; 56:6478-94. [DOI: 10.1021/jm400778d] [Citation(s) in RCA: 77] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Masanori Okaniwa
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Masaaki Hirose
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Takeo Arita
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Masato Yabuki
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Akito Nakamura
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Terufumi Takagi
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Tomohiro Kawamoto
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Noriko Uchiyama
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Akihiko Sumita
- CMC Center, Takeda Pharmaceutical Company Limited, 17-85 Jusohonmachi 2-chome,
Yodogawa-ku, Osaka 532-8686, Japan
| | - Shunichirou Tsutsumi
- CMC Center, Takeda Pharmaceutical Company Limited, 17-85 Jusohonmachi 2-chome,
Yodogawa-ku, Osaka 532-8686, Japan
| | - Tsuneaki Tottori
- CMC Center, Takeda Pharmaceutical Company Limited, 17-85 Jusohonmachi 2-chome,
Yodogawa-ku, Osaka 532-8686, Japan
| | - Yoshitaka Inui
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Bi-Ching Sang
- Structural Biology, Takeda California, Inc., 10410 Science Center Drive,
San Diego, California 92121, United States
| | - Jason Yano
- Structural Biology, Takeda California, Inc., 10410 Science Center Drive,
San Diego, California 92121, United States
| | - Kathleen Aertgeerts
- Structural Biology, Takeda California, Inc., 10410 Science Center Drive,
San Diego, California 92121, United States
| | - Sei Yoshida
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Tomoyasu Ishikawa
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi
2-chome, Fujisawa, Kanagawa 251-8555, Japan
| |
Collapse
|
199
|
Blundell CD, Packer MJ, Almond A. Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation. Bioorg Med Chem 2013; 21:4976-87. [PMID: 23886813 PMCID: PMC3744816 DOI: 10.1016/j.bmc.2013.06.056] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2013] [Accepted: 06/24/2013] [Indexed: 12/22/2022]
Abstract
Accurate unbound solution 3D-structures of ligands provide unique opportunities for medicinal chemistry and, in particular, a context to understand binding thermodynamics and kinetics. Previous methods of deriving these 3D-structures have had neither the accuracy nor resolution needed for drug design and have not yet realized their potential. Here, we describe and apply a NMR methodology to the aminoglycoside streptomycin that can accurately quantify accessible 3D-space and rank the occupancy of observed conformers to a resolution that enables medicinal chemistry understanding and design. Importantly, it is based upon conventional small molecule NMR techniques and can be performed in physiologically-relevant solvents. The methodology uses multiple datasets, an order of magnitude more experimental data than previous NMR approaches and a dynamic model during refinement, is independent of computational chemistry and avoids the problem of virtual conformations. The refined set of solution 3D-shapes for streptomycin can be grouped into two major families, of which the most populated is almost identical to the 30S ribosomal subunit bioactive shape. We therefore propose that accurate unbound ligand solution conformations may, in some cases, provide a subsidiary route to bioactive shape without crystallography. This experimental technique opens up new opportunities for drug design and more so when complemented with protein co-crystal structures, SAR data and pharmacophore modeling.
Collapse
Affiliation(s)
- Charles D Blundell
- C4X Discovery Ltd, Unit 310 Ducie House, Ducie Street, Manchester M1 2JW, UK
| | | | | |
Collapse
|
200
|
Bent bonds and the antiperiplanar hypothesis as a simple model to predict Diels–Alder reactivity: retrospective or perspective? Tetrahedron 2013. [DOI: 10.1016/j.tet.2013.05.008] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|